Summary
Specific binding of [3H]imipramine and [3H]paroxetine was simultaneously examined in human brains (frontal cortex, temporal cortex, cingulate cortex, hypothalamus, hippocampus and amygdala) from 11 controls and 11 depressed suicide victims. A single saturable high affinity site was obtained for both radioligands. Age was not related to significant changes in [3H]imipramine and [3H]paroxetine binding parameters, which indicates the stability of the brain serotonergic system with increasing age.
A major finding of the present study concerns the existence of a significant decrease in the maximum number (Bmax) of [3H]imipramine binding sites in hippocampus from depressed suicides as compared with the control group, without changes in the binding affinity (Kd). In contrast, when [3H]paroxetine was used as radioligand, no changes in either Bmax or Kd were detected in any of the brain regions studied. These findings suggest that [3H]imipramine may be a better marker than [3H]paroxetine when alterations in the presynaptic serotonergic uptake site are to be detected.
Similar content being viewed by others
References
Andersson A, Marcusson J (1990) 3H-paroxetine binding in human platelets in relation to age and sex. Neurobiol Aging 11(6): 615–618
Andersson A, Sundman I, Marcusson J (1992) Age stability of human brain 5HT terminals studied with [3H]paroxetine binding. Gerontology 38: 127–132
Ambrosini PJ, Metz C, Arora RC, Lee JC, Kregel L, Meltzer HY (1991) The association between platelet imipramine binding site and suicide (letter). Pharmacopsychiatry 24(6): 23
Arora RC, Meltzer HY (1989) [3H]imipramine binding in the frontal cortex of suicides. Psychiatry Res 30: 125–135
Arranz B, Eriksson A, Mellerup E, Plenge P, Marcusson J (1994a) Brain 5-HT1A, 5-HT1D and 5-HT2 receptors in suicide victims. Biol Psychiatry 35: 457–463
Arranz B, Marcusson J (1994b) [3H]paroxetine and [3H]citalopram as markers of the human brain 5-HT uptake site: a comparison study. J Neural Transm 97: 27–40
Asberg M, Thoren P, Traskman L (1976) “Serotonin depression” a biochemical subgroup within the affective disorders. Science 191: 478–480
Bäckstrom IT, Marcusson JO (1987) 5-Hydroxytryptamine-sensible [3H]imipramine binding of protein nature in the human brain. I. Characteristics. Brain Res 425: 128–136
Barraclough B, Bunch J, Nelson B, Sainsbury P (1974) A hundred cases of suicide: clinical aspects. Br J Psychiatry 125: 355–373
Cumming P, Gjedde A (1993) Kinetics of the uptake of [3H]paroxetine in the rat brain. Synapse 15: 124–129
Gobbi M, Taddei C, Mennini T (1987) Different components of [3H]imipramine binding in rat brain membranes: relation to serotonin uptake sites. Life Sci 42: 575–583
Habert E, Graham D, Tahraoui L, Claustre Y, Langer SZ (1985) Characterization of [3H]paroxetine binding to rat cortical membranes. Eur J Pharmacol 118: 107–114
Hrdina PD, Demeter E, Vu TB, Sotonyi P, Palkovits M (1993) 5-HT uptake sites and 5-HT2 receptor in brain of antidepressant-free suicide victims depressives: increase in 5-HT2 sites in cortex and amygdala. Brain Res 614: 37–44
Inyl L, Meaney M, Desjardins P, Nair NPV, Pecknold J, Schwartz G, Quirion R, Suranyi-Cadotte B (1989) [3H]imipramine and [3H]paroxetine binding in blood platelets of psychiatric patients and healthy volunteers. J Psychopharmacol 3: 78–83
Langer SZ, Galzin AM, Poirier MF, Loo H, Sechter D, Zarifian E (1987) Association of [3H]imipramine and [3H]paroxetine binding with the 5-HT transporter in brain and platelets: relevance to studies in depression. J Recept Res 7: 499–521
Lawrence KM, De Paermentier F, Chletham SC, Cromptom MR, Katona CL, Horton RW (1990) Brain 5-HT uptake sites labelled with [3H]paroxetine in antidepressant- free depressed suicides. Brain Res 526: 17–22
Mann JJ, Stanley M, Mc Bride PD, Mc Ewen BS (1986) Increased serotonin2 and β-adrenergic receptor binding in the frontal cortices of suicide victims. Arch Gen Psychiatry 43: 854–959
Marcusson J, Alafuzoff I, Bäckstrom IT, Erikson E, Gotffries CG, Winblad B (1987) 5-Hydroxytryptamine-sensitive [3H]imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders. Brain Res 425: 137–145
Marcusson JO, Bergstrom M, Eriksson K, Ross SB (1988) Characterization of [3H]paroxetine binding in rat brain. J Neurochem 50: 1783–1790
Markwell Ma, Heas SM, Bieber LL, Tolbert Ne (1987) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 203–225
Mellerup ET, Plenge P, Nielsen M (1985) Size determination of binding polymers for [3H]imipramine and [3H]paroxetine in human membranes. Eur J Pharmacol 106: 411–413
Molcho A, Stanley B, Stanley M (1991) Biological studies and markers in suicide and attempted suicide. Int Clin Psychopharmacol 6: 77–92
Montgomery SA, Montgomery D (1982) Pharmacological prevention of suicidal behaviour. J Affect Disord 4: 291–298
Murphy DL, Campbell IC, Costa JL (1978) The brain serotoninergic system in the affective disorders. Neuropsychopharmacology 2: 1–31
Owen F, Chambers DR, Cooper SJ, Crow TJ, Johnson JA, Lofthouse R, Poulter M (1986) Serotonergic mechanisms in brains of suicide victims. Brain Res 362: 185–188
Owens MJ, Nemeroff CB (1994) Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter. Clin Chem 40: 288–295
Palkovits M, Raisman R, Briley M, Langer SZ (1981) Regional distribution of [3H]imipramine binding in rat brain. Brain Res 210: 493–498
Pandey GN, Pandey SC, Dwivedi Y, Sharna RP, Janicak PG, Davis JM (1995) Platelet serotonin-2A receptors: a potencial biological marker for suicidal behaviour. Am J Psychiatry 152: 850–855
Plenge P, Mellerup ET, Laursen H (1990) Regional distribution of the serotonin transport complex in human brain, identified with [3H]paroxetine [3H]citalopram and [3H]imipramine. Prog Neuropsychopharmacol 14: 61–72
Plenge P, Mellerup ET, Laursen H (1991) Affinity modulation of [3H]imipramine, [3H]paroxetine and [3H]citalopram binding to the 5-HT transporter from brain and platelets. Eur J Pharmacol 206: 243–250
Raisman R, Briley MS, Langer SZ (1979) High affinity [3H]imipramine binding in rat cerebral cortex. Eur J Pharmacol 58: 347–348
Raisman R, Briley MS, Bouchami F, Sechter D, Zarifian E, Langer SZ (1982) [3H]imipramine binding and serotonin uptake in platelets from untreated depressed and controls volunteers. Psychopharmacology 77: 332–335
Rehavi M, Paul SM, Skolnick P, Goodwin FK (1980) Demonstration of high-affinity binding sites for [3H]imipramine in human brain. Life Sci 26: 2273–2279
Rej R, Richards AH (1974) Interference by tris buffer in the estimation of protein by the Lowry procedure. Anal Biochem 62: 240–247
Risch SC, Nemeroff CB (1992) Neurochemical alterations of serotonergic neuronal system in depression. J Clin Psychiatry 53: 3–7
Rosel P, Vallejo J, Oros M, Serrallonga J, Menchón JM, Navarro MA (1995) Changes in platelet [3H]imipramine binding: influences of protein concentration of varying proportions of cytosol or intact platelets and displacing agents used. Biol Psychiatry 38: 464–470
Rosel P, Vallejo J, Oros M, Menchón JM, Cortadellas T, Navarro MA, Urretavizcaya M (1996) Seasonal variability in blood platelet [3H]imipramine binding in healthy controls: age and gender effects. Biol Psychiatry 40: 981–985
Rosel P, Menchon JM, Oros M, Vallejo J, Cortadellas T, Arranz B, Alvarez P, Navarro MA (1997a) Regional distribution of specific high affinity binding sites for [3H]imipramine and [3H]paroxetine in human brain. J Neural Transm 104: 89–96
Rosel P, Menchón JM, Vallejo J, Arranz B, Navarro MA, Lirón F, Alvarez P (1997b) Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients. J Affect Disord 44: 79–85
Stanley M, Stanley B (1990) Postmortem evidence for serotonin's role in suicide. J Clin Psychiatry 51(4): 22–28
Stanley M, Virgilio S, Gershon S (1982) Tritiated imipramine binding sites are decrease in the frontal cortex of suicides. Science 216: 1337–1339
Suranyi-Cadotte BE, Inyl L, Desjardins P, Jassa R, Weiner S (1989) Decreased density of platelet [3H]imipramine but not [3H]paroxetine binding sites in major depression. Soc Neurosci Abstract 274.4
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Rosel, P., Arranz, B., Vallejo, J. et al. High affinity [3H]imipramine and [3H]paroxetine binding sites in suicide brains. J. Neural Transmission 104, 921–929 (1997). https://doi.org/10.1007/BF01285560
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01285560